VYNE Therapeutics Inc.

Report date
12/31/2022
Quarter
2022 Q4
Filed
5/15/2023
Shares
210,046
Value ($000)
32
Weight
0.0%
2021 Q1 - 2022 Q4 (8 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).